Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-19 Purchase |
2020-08-21 4:17 pm |
Kintara Therapeutics Inc. | KTRA | Liatos John SVP, Business Development |
196,750 | $0 | $0 | 196,750 (Direct) |
View |
| 2020-08-19 Purchase |
2020-08-21 4:16 pm |
Kintara Therapeutics Inc. | KTRA | Murphy Keith Director |
181,010 | $0 | $0 | 181,010 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-22 Option Award |
2021-09-22 8:40 pm |
N/A 2031-09-22 |
Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-22 8:37 pm |
N/A 2031-09-22 |
Kintara Therapeutics Inc. | KTRA | SEYMOUR TAMARA A Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-22 8:35 pm |
N/A 2031-09-22 |
Kintara Therapeutics Inc. | KTRA | HOFFMAN ROBERT Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-22 8:31 pm |
N/A 2031-09-22 |
Kintara Therapeutics Inc. | KTRA | Johnson Laura L. Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-04-29 Option Award |
2021-05-03 4:34 pm |
N/A 2031-04-29 |
Kintara Therapeutics Inc. | KTRA | SEYMOUR TAMARA A Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-04-29 Other |
2021-04-29 4:06 pm |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer |
6 | $0 | 60,574 (Direct) |
View |
| 2021-04-29 Conversion |
2021-04-29 4:06 pm |
2016-04-29 N/A |
Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer |
3,750 | $0 | 60,574 (Direct) |
View |
| 2021-04-29 Other |
2021-04-29 4:06 pm |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer |
8 | $0 | 8,494 (Direct) |
View |
| 2021-04-29 Conversion |
2021-04-29 4:06 pm |
2016-04-29 N/A |
Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer |
4,688 | $0 | 8,494 (Direct) |
View |
| 2021-04-29 Other |
2021-04-29 4:05 pm |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director |
3 | $0 | 1,569 (Direct) |
View |
| 2021-04-29 Conversion |
2021-04-29 4:05 pm |
2016-04-29 N/A |
Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director |
1,625 | $0 | 1,569 (Direct) |
View |
| 2021-03-31 Other |
2021-03-31 4:14 pm |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director |
8 | $0 | 1,246 (Direct) |
View |
| 2021-03-31 Other |
2021-03-31 4:11 pm |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer |
17 | $0 | 59,829 (Direct) |
View |
| 2021-03-31 Other |
2021-03-31 4:08 pm |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer |
22 | $0 | 7,562 (Direct) |
View |
| 2020-12-31 Other |
2021-01-04 08:01 am |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer |
17 | $0 | 59,812 (Direct) |
View |
| 2020-12-31 Other |
2021-01-04 08:00 am |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director |
8 | $0 | 1,238 (Direct) |
View |
| 2020-12-31 Other |
2021-01-04 08:00 am |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer |
22 | $0 | 7,540 (Direct) |
View |
| 2020-09-30 Other |
2020-09-30 4:06 pm |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director |
8 | $0 | 1,230 (Direct) |
View |
| 2020-09-30 Other |
2020-09-30 4:06 pm |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer |
22 | $0 | 7,518 (Direct) |
View |
| 2020-09-30 Other |
2020-09-30 4:05 pm |
N/A N/A |
Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer |
17 | $0 | 59,795 (Direct) |
View |
| 2020-09-22 Option Award |
2020-09-24 7:31 pm |
N/A 2030-09-22 |
Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientifc Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 9:12 pm |
N/A 2030-09-15 |
Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer |
606,557 | $0 | 606,557 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 9:09 pm |
N/A 2030-09-15 |
Kintara Therapeutics Inc. | KTRA | Liatos John SVP, Business Development |
506,647 | $0 | 506,647 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 9:08 pm |
N/A 2030-09-15 |
Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer |
87,437 | $0 | 87,437 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 9:07 pm |
N/A 2030-09-15 |
Kintara Therapeutics Inc. | KTRA | Zarrabian Saiid President and CEO |
2,715,004 | $0 | 2,715,004 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 9:05 pm |
N/A 2030-09-15 |
Kintara Therapeutics Inc. | KTRA | HOFFMAN ROBERT Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 9:03 pm |
N/A 2030-09-15 |
Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 9:00 pm |
N/A 2030-09-15 |
Kintara Therapeutics Inc. | KTRA | Murphy Keith Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 8:59 pm |
N/A 2030-09-15 |
Kintara Therapeutics Inc. | KTRA | Johnson Laura L. Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2020-06-30 Other |
2020-06-30 4:17 pm |
N/A N/A |
DelMar Pharmaceuticals Inc. | DMPI | Praill Anthony Scott Chief Financial Officer |
22 | $0 | 115,862 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 4:17 pm |
N/A 2029-09-05 |
DelMar Pharmaceuticals Inc. | DMPI | Praill Anthony Scott Chief Financial Officer |
57,170 | $0 | 115,862 (Direct) |
View |
| 2020-06-30 Other |
2020-06-30 4:16 pm |
N/A N/A |
DelMar Pharmaceuticals Inc. | DMPI | Cranston Lynda Sarah Director |
8 | $0 | 75,340 (Indirect) |
View |
| 2020-06-26 Option Award |
2020-06-30 4:16 pm |
N/A 2029-09-05 |
DelMar Pharmaceuticals Inc. | DMPI | Cranston Lynda Sarah Director |
39,567 | $0 | 75,340 (Direct) |
View |
| 2020-06-30 Other |
2020-06-30 4:14 pm |
N/A N/A |
DelMar Pharmaceuticals Inc. | DMPI | Bell John K Director |
29 | $0 | 119,846 (Indirect) |
View |
| 2020-06-26 Option Award |
2020-06-30 4:14 pm |
N/A 2029-09-05 |
DelMar Pharmaceuticals Inc. | DMPI | Bell John K Director |
39,567 | $0 | 119,846 (Direct) |
View |
| 2020-06-30 Other |
2020-06-30 4:12 pm |
N/A N/A |
DelMar Pharmaceuticals Inc. | DMPI | TOTH ROBERT JOSEPH JR Director |
8 | $0 | 76,222 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 4:12 pm |
N/A 2029-09-05 |
DelMar Pharmaceuticals Inc. | DMPI | TOTH ROBERT JOSEPH JR Director |
39,567 | $0 | 76,222 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 4:11 pm |
N/A 2029-09-05 |
DelMar Pharmaceuticals Inc. | DMPI | HOFFMAN ROBERT Director |
39,567 | $0 | 75,000 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 4:09 pm |
N/A 2029-09-05 |
DelMar Pharmaceuticals Inc. | DMPI | Ferrara Napoleone Director |
39,567 | $0 | 75,000 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 4:08 pm |
N/A 2029-09-05 |
DelMar Pharmaceuticals Inc. | DMPI | Zarrabian Saiid President and CEO |
241,438 | $0 | 457,650 (Direct) |
View |
| 2020-06-30 Other |
2020-06-30 4:07 pm |
N/A N/A |
DelMar Pharmaceuticals Inc. | DMPI | Brown Dennis M Chief Scientific Officer |
17 | $0 | 409,778 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 4:07 pm |
N/A 2029-09-05 |
DelMar Pharmaceuticals Inc. | DMPI | Brown Dennis M Chief Scientific Officer |
302,756 | $0 | 409,778 (Direct) |
View |